Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.
J Intern Med. 2023 Sep;294(3):295-313. doi: 10.1111/joim.13674. Epub 2023 Jun 8.
J Intern Med. 2023.
PMID: 37259686
[Novelties in the diagnostics and therapy of hairy cell leukemia].
Sári E, Rajnai H, Dénes K, Bödör C, Csomor J, Körösmezey G, Tárkányi I, Eid H, Nagy Z, Demeter J.
Sári E, et al. Among authors: korosmezey g.
Magy Onkol. 2016 Jun 6;60(2):137-44. Epub 2016 Apr 15.
Magy Onkol. 2016.
PMID: 27275640
Free article.
Review.
Hungarian.
Item in Clipboard
[Treatment options and limitations in the management of myelofibrosis].
Körösmezey G, Gyõri G, Rudas G, Eid H, Nagy Z, Demeter J.
Körösmezey G, et al.
Magy Onkol. 2017 Mar 8;61(1):47-55. Epub 2016 May 12.
Magy Onkol. 2017.
PMID: 28273188
Free article.
Review.
Hungarian.
Item in Clipboard
[Novelties and experience with tyrosine kinase inhibitor therapy in chronic myeloid leukemia].
Gaál-Weisinger J, Mucsi O, Körösmezey G, Szili B, Eid H, Kiss R, Bödör C, Tárkányi I, Nagy Z, Demeter J.
Gaál-Weisinger J, et al. Among authors: korosmezey g.
Magy Onkol. 2017 Mar 8;61(1):67-74. Epub 2017 Feb 3.
Magy Onkol. 2017.
PMID: 28273190
Free article.
Review.
Hungarian.
Item in Clipboard
Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms.
Gángó A, Mózes R, Boha Z, Kajtár B, Timár B, Király PA, Kiss R, Fésüs V, Nagy N, Demeter J, Körösmezey G, Borbényi Z, Marton I, Szőke A, Masszi T, Farkas P, Várkonyi J, Plander M, Pósfai É, Egyed M, Pál K, Radványi G, Hamed A, Csomor J, Matolcsy A, Alpár D, Bödör C.
Gángó A, et al. Among authors: korosmezey g.
Leuk Res. 2018 Feb;65:42-48. doi: 10.1016/j.leukres.2017.12.005. Epub 2018 Jan 2.
Leuk Res. 2018.
PMID: 29306106
Item in Clipboard
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
László T, Kotmayer L, Fésüs V, Hegyi L, Gróf S, Nagy Á, Kajtár B, Balogh A, Weisinger J, Masszi T, Nagy Z, Farkas P, Demeter J, Istenes I, Szász R, Gergely L, Sulák A, Borbényi Z, Lévai D, Schneider T, Pettendi P, Bodai E, Szerafin L, Rejtő L, Bátai Á, Dömötör MÁ, Sánta H, Plander M, Szendrei T, Hamed A, Lázár Z, Pauker Z, Radványi G, Kiss A, Körösmezey G, Jakucs J, Dombi PJ, Simon Z, Klucsik Z, Gurzó M, Tiboly M, Vidra T, Ilonczai P, Bors A, Andrikovics H, Egyed M, Székely T, Masszi A, Alpár D, Matolcsy A, Bödör C.
László T, et al. Among authors: korosmezey g.
J Pathol Clin Res. 2024 Jan;10(1):e351. doi: 10.1002/cjp2.351. Epub 2023 Nov 21.
J Pathol Clin Res. 2024.
PMID: 37987115
Free PMC article.
Item in Clipboard
Cite
Cite